Medium-term Bedrest Whey Protein (MEP) (MEP)
Sponsor: Charite University, Berlin, Germany
This NA trial investigates Countermeasure Evaluation and is currently completed. Charite University, Berlin, Germany leads this study, which shows 6 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Mar 2022 — Jul 2024 [monthly]
Completed NA
-
Jan 2021 — Mar 2022 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Aug 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Charite University, Berlin, Germany
- DLR German Aerospace Center
- European Space Agency
- Institut Pluridisciplinaire Hubert Curien, Strasbourg, France
- Leiden University Medical Center
- Manchester Metropolitan University
- Medical University of Graz
- Radboud University Medical Center
- University Hospital, Clermont-Ferrand
- University Hospital, Lille
- University of Cologne
- University of Milan
- University of Ottawa
- University of Toronto
- Université de Nice Sophia Antipolis
For direct contact, visit the study record on ClinicalTrials.gov .